Skip to main content

Table 2 The clinicopathological factors in 62 PTC patients

From: Evaluate the immune-related eRNA models and signature score to predict the response to immunotherapy in thyroid carcinoma

Characteristics

Samples(N = 62)

Percentage (%)

Age

 ≤ 60

54

87.1

 > 60

8

12.9

Gender

 Female

45

72.6

 Male

17

27.4

Tumor size

 < 2 cm

43

69.4

 ≥ 2 cm

19

30.6

Extrathyroidal invasion

 Yes

7

11.3

 No

55

88.7

Multicentricity

 Yes

23

37.1

 No

39

62.9

Stage

 Stage I–II

56

90.3

 Stage III–IV

6

9.7

T

 T1-2

41

66.1

 T3-4

21

33.9

N

 N0

18

29.0

 N1

44

71.0